1. Home
  2. PFAI vs CVM Comparison

PFAI vs CVM Comparison

Compare PFAI & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PFAI

Pinnacle Food Group Limited

HOLD

Current Price

$2.62

Market Cap

27.1M

ML Signal

HOLD

Logo Cel-Sci Corporation

CVM

Cel-Sci Corporation

HOLD

Current Price

$3.20

Market Cap

32.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PFAI
CVM
Founded
2015
1983
Country
Canada
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.1M
32.4M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
PFAI
CVM
Price
$2.62
$3.20
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
6.4K
35.8K
Earning Date
05-02-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$264,033.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
65.45
52 Week Low
$1.30
$0.18
52 Week High
$4.93
$13.48

Technical Indicators

Market Signals
Indicator
PFAI
CVM
Relative Strength Index (RSI) 60.53 30.83
Support Level $2.22 $2.02
Resistance Level $2.80 $6.75
Average True Range (ATR) 0.12 0.30
MACD 0.01 0.02
Stochastic Oscillator 82.26 3.49

Price Performance

Historical Comparison
PFAI
CVM

About PFAI Pinnacle Food Group Limited

Pinnacle Food Group Ltd is a provider of smart farming solutions focused on vertical and hydroponic farming. The company focuses on promoting sustainable food security by developing and building customized smart farming systems for customers based on the systematic integration of technology, hardware, and software, coupled with a full range of integrated supply and technical services. It sells hydroponic growing systems and technical support services to individual households and community groups, and is developing a hydroponic growing system for urban farms. Geographically, the company generates the majority revenue from Canada, followed by New Zealand.

About CVM Cel-Sci Corporation

CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused on the development of the following product candidates and technologies: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of certain head and neck cancers; 2) LEAPS (Ligand Epitope Antigen Presentation System) technology, for the potential treatment of rheumatoid arthritis.

Share on Social Networks: